Doranidazole Enhances Radiation Effects in Colorectal Cancer Cells
Author Information
Author(s): Zhang Li, Gong Aimin, Ji Jun, Wu Yuanyuan, Zhu Xiaoyu, Lv Suqing, Lv Hongzhu, Sun Xizhuo
Primary Institution: Dalian Municipal Central Hospital
Hypothesis
Does doranidazole enhance the radiosensitivity of human colorectal cancer cells exposed to high doses of irradiation?
Conclusion
Doranidazole can enhance the killing effect and the cell growth inhibition of colorectal cancer after high-dose irradiation in a time and dose-dependent manner.
Supporting Evidence
- Doranidazole significantly inhibited cell proliferation at doses of 10 to 30 Gy of irradiation.
- The radiosensitizing effect of doranidazole was time- and dose-dependent.
- Doranidazole reduced cell migration and invasion in colorectal cancer cells.
Takeaway
Doranidazole helps make cancer cells more sensitive to radiation, which means it can kill more cancer cells when used with high doses of radiation.
Methodology
The study used colony formation and propidium iodide assays to measure cell growth inhibition and cell death in colorectal cancer cell lines under hypoxic conditions after irradiation.
Limitations
The study was conducted in vitro, and results may not fully translate to in vivo conditions.
Participant Demographics
Five human colorectal cancer cell lines were used: HT-29, DLD-1, Colo 201, LoVo, and SW620.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website